Skip to search formSkip to main contentSkip to account menu

Erythromycin 500 MG Delayed Release Oral Tablet [PCE]

Known as: ERYTHROMYCIN ETHYLSUCCINATE 500 mg ORAL TABLET [PCE], PCE 500 MG Delayed Release Oral Tablet 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
This paper describes the experience of designing, implementing, and evaluating a carrier-grade transport network with stateful… 
2015
2015
The present different types of industrial applications and products make use of electromagnetic energy. One way to this energy… 
2014
2014
Relevant benefits of the active stateful PCE architecture are experimentally demonstrated on a flexgrid network testbed. Two… 
2013
2013
At numerous sites in Denmark and other countries, contaminant source areas are located in low permeable deposits. Succesfull… 
2012
2012
The virtual circuit characteristic of MPLS and GMPLS architectures has enabled the implement of Traffic Engineering (TE) and… 
2006
2006
The 880 nm diode laser is emerging as the source of choice for pumping Nd:YV04 laser crystals because it offers higher pumping… 
2005
2005
ABSTRACT Coccidioides spp. (immitis and posadasii) are the causative agents of human coccidioidomycosis. In this study, we… 
2001
2001
The flow cytometer‐based micronucleus assay was used to study the effects on chromosomes in erythroid cells of CBA/Ca mice after…